The committee meets in Iowa City once each year with the leadership, members and staff of the Holden Comprehensive Cancer Center. Committee members provide guidance and consultation to the leadership team of the Holden Comprehensive Cancer Center regarding various aspects of the Cancer Center's activities including:

• Organizational structure
• Scientific program development
• Shared research resources
• New approaches to strengthening the research, clinical and educational activities of the Cancer Center

Committee composition:

Francis Ali-Osman, D.Sc.
Margaret Harris and David Silberman Distinguished Professor
Department of Surgery
Head, Experimental Therapeutics Program
Associate Director for Translational Research, Duke Comprehensive Cancer Center
Duke University Medical Center
Durham, NC

Carlos L. Arteaga, M.D.
Professor of Medicine and Cancer Biology
Director, VICC Breast Cancer Program
Division of Hematology/Oncology
Vanderbilt University Medical Center
Nashville, TN

Stanton L. Gerson, M.D.
Director, Case Comprehensive Cancer Center
Director, Ireland Cancer Center
Director, Center for Stem Cell and Regenerative Medicine
Cleveland, OH 

Stuart M. Lichtman, MD
Associate Attending
Memorial Sloan-Kettering Cancer Center
Commack, New York

Steven Rosen, MD, Chair
Director, Robert H. Lurie Comprehensive Cancer Center
Genevieve Teuton Professor of Medicine
Northwestern University, Chicago, IL

Thomas A. Sellers, PhD, MPH
Director, Moffitt Research Institute
Associate Center Director, Cancer Prevention & Control Executive Vice President
H. Lee Moffitt Cancer Center & Research Institute Tampa, FL

Brian C. Springer, MHA
Executive Director
Research and Business Administration
Alvin J. Siteman Cancer Center
St. Louis, MO 

Donald L. Trump, MD
President & CEO
Roswell Park Cancer Institute
Buffalo, NY